Interleukin-36-receptor antagonist deficiency and generalized pustular psoriasis.

By S. Marrakchi, P. Guigue, B. Renshaw, A. Puel, X. Pei, S. Fraitag, J. Zribi, E. Bal, C. Cluzeau, Maya Chrabieh and 20 more. New England Journal of Medicine, 2011

915 citations recorded by the source corpus.

Subfields: Dermatology, Immunology, Rheumatology

View Paper: https://www.semanticscholar.org/paper/ef46c4b296219e2522665b0db60369a90ce13234

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Dermatology

1. Adriana Rendon
2. K. Schäkel

In Immunology

1. Adriana Rendon
2. K. Schäkel

Citations in the corpus

• THE INTERLEUKIN-1 FAMILY: BACK TO THE FUTURE (2013, neutral): “IL36RN (IL-36Ra, human) Severe psoriasis (Marrakchi et al., 2011)”
• Psoriasis Pathogenesis and Treatment (2019, background): “For instance, mutations in the antagonist to the IL-36 receptor (IL-36RN), belonging to the IL-1 pro-inflammatory cytokine family, have been linked to pustular psoriasis [118,119].”